Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

PharmaMar's Yondelis completes requirements for launch in Spain

Dec. 31, 2007

Endocyte and R&D-Biopharmaceuticals enter tubulysin chemo agent agreement

Dec. 31, 2007

Cell Therapeutics completes Zevalin's acquisition for U.S. sales and marketing

Dec. 31, 2007

Phase I trial commences for Cougar Biotechnology's CB-3304

Dec. 31, 2007

Progen's phase III study of PI-88 for HCC open for recruitment

Dec. 31, 2007

Phase II IPI-504 trial initiated in patients with non-small cell lung cancer

Dec. 28, 2007

Peregrine gives update on its three lead clinical programs for bavituximab and Cotara

Dec. 28, 2007

Tissue-specific FAK gene deletion blocks mammary tumor progression

Dec. 28, 2007

Preliminary phase I results with AT-9283 in hematological malignancies encouraging

Dec. 28, 2007

Activity seen with SNS-595 in acute leukemia patients

Dec. 28, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...